Bexxar

DRUG3 trials

Sponsors

University of Pennsylvania, Susan Knox, University of Michigan Rogel Cancer Center

Conditions

B-cell LymphomaFollicular LymphomaLymphomaNon-Hodgkin's Lymphoma

Phase 1

Safety and Efficacy of Bexxar Therapy in the Treatment of Relapsed/Residual B-Cell Lymphoma After Autologous Transplant

CompletedNCT00434629

University of PennsylvaniaB-cell Lymphoma, Non-Hodgkin's Lymphoma

Start: 2007-02-28End: 2015-05-31Updated: 2016-08-17

Phase 2

Phase 2 Study of Bexxar in Relapsed/Refractory DLCL

CompletedNCT00490009

Susan KnoxLymphoma

Start: 2004-09-30End: 2013-06-30Updated: 2017-03-30

Trial of Low-Dose Methotrexate and I 131 Tositumomab for Previously Untreated, Advanced-Stage, Follicular Lymphoma

TerminatedNCT01389076

University of Michigan Rogel Cancer CenterFollicular Lymphoma

Start: 2011-07-31End: 2016-06-30Updated: 2017-01-30